Haemodynamics and structural interventional cardiology

1. Ferlini M. et al. Follow-up strategies and individual risk profile after percutaneous coronary intervention: The prospective post percutaneous coronary intervention registry. Catheterization and Cardiovascular Interventions, 2021;
    
2. Ferlini M. et al. Perceived or Calculated Bleeding Risk and Their Relation With Dual Antiplatelet Therapy Duration in Patients Undergoing Percutaneous Coronary Intervention. Catheterization and Cardiovascular Interventions, 2019;
    
3. Ferlini M. et al.  Acute coronary syndromes during the first and the second wave of COVID-19. European Journal of Internal Medicine, 2022;
    
4. Ferlini M. et al. Oral aspirin or low dose of intravenous lysine acetylsalicylate in ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Journal of Cardiovascular Medicine (Hagerstown), 2021;
    
5. Iannopollo G., Ferlini M. et al. Patient Outcomes With STEMI Caused by Aneurysmal Coronary Artery Disease and Treated With Primary PCI. Journal of the American College of Cardiology, 2017.

• Last generation drug eluting stents
• Current available transcatheter bioprosthetic valves
• Current available transcatheter edge-to-edge mitral valve repair
• Current available transcatheter device for PFO/DIA closure
• Coronary imaging
• Functional coronary stenosis evaluation
• Short-term mechanical circulatory support (MCS)

Italian Society of Intervantional Cardiology (GISE).